Contact

For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.

  • We don’t offer sessions of ayahuasca or iboga.
  • We don’t recommend centers or people who perform/do sessions.

    map mapa marcador ICEERS

    Office

    Carrer de SepĂșlveda, 65 , Oficina 2, 08015 Barcelona España +34 931 88 20 99
    medical cannabis patients chronic illnesses Catalan enfermedades crĂłnicas ICEERS study

    Study: Medical Cannabis in Patients with Chronic Illnesses

    04.10.2021

    Assessment of the health status, consumption patterns and subjective benefits of medical cannabis in a sample of Catalan patients with chronic illnesses

    Authors:
    Daniel F. Jiménez-Garrido, Genís Oña, Pep Cura, Alícia ParÚs, Beatriz Aparecida Passos Bismara Paranhos, Felipe de Almeida Mendes, Mauricio Yonamine, Rafael G. dos Santos, Jaime E.C. Hallak, Miguel Ángel Alcåzar-Córcoles, and José Carlos Bouso.

    Journal:
    Circular Farmacéutica

    Year:
    2021

    About the study

    This cross-sectional study describes the social and health realities of a sample of Catalan therapeutic cannabis users with chronic illnesses, with the aim that professional pharmacists and other health professionals can learn in detail how this practice works.

    The recruitment of participants with chronic illnesses was carried out through different associations of patients who use cannabis and among cannabis clubs where we left information sheets about the study with the contact of ICEERS, who collaborates actively with the Department of Health of the Generalitat de Catalunya in training and research aspects related to the phenomenon of Cannabis Social Clubs.

    “We designed a semi-structured interview with 27 items grouped into four categories: sociodemographic information, health indicators from the Health Survey of Catalonia (ESCA) and the General Health Questionnaire-12 (GHQ-12) scale, cannabis use and, finally, a retrospective health questionnaire referring to subjective general health items, mental well-being, use of emergency services or hospitalisation and total or partial substitution of some medication as if the response had been 12 months before starting to use cannabis.”

    In conclusion, there is a wide range of patients who use cannabis to alleviate some symptoms of chronic conditions, mainly related to inflammation and pain. After starting to use cannabis, patients abandon some prescription drugs and the number of visits to the emergency room or hospital stays decreases, circumstances that can lead to an improvement in quality of life and significant savings for public health systems.

     

    Abstract

    Not available.

     

    Link to the article

     
    Photo by kazuend on Unsplash.

    Categories: Studies & papers , Cannabis
    Tags: cannabis , scientific research , study , medical cannabis , epidemiology , chronic disease